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The in vitromethods currently used to screen bioactive compounds focus on the use of a single model of oxidative stress. However,
this simplistic view may lead to conflicting results. The aim of this study was to evaluate the antioxidant properties of two natural
extracts (amix of red wine polyphenols (RWPs) and epigallocatechin gallate (EGCG)) with threemodels of oxidative stress induced
with hydrogen peroxide (H
2
O
2
), a mixture of hypoxanthine and xanthine oxidase (HX/XO), or streptozotocin (STZ) in RINm5F
beta cells. We employed multiple approaches to validate their potential as therapeutic treatment options, including cell viability,
reactive oxygen species production, and antioxidant enzymes expression. All three oxidative stresses induced a decrease in cell
viability and an increase in apoptosis, whereas the level of ROS production was variable depending on the type of stress.The highest
level of ROS was found for the HX/XO-induced stress, an increase that was reflected by higher expression antioxidant enzymes.
Further, both antioxidant compounds presented beneficial effects during oxidative stress, but EGCG appeared to be amore efficient
antioxidant. These data indicate that the efficiency of natural antioxidants is dependent on both the nature of the compound and
the type of oxidative stress generated.
1. Introduction
Oxidative stress can be defined as an imbalance between pro-
and antioxidants and is often associated with free radical
[1] overproduction and/or defective physiological defence
mechanisms resulting in the cell being overwhelmed with
oxidizing radicals [2]. This phenomenon involves reactive
oxygen species [3], such as superoxide anion (O2
−) [4], hyd-
roxyl radical (OH∙) [1], singlet oxygen (1O2), and hydrogen
peroxide (H
2
O
2
) [5]. High concentrations of ROS can cause
lipid peroxidation, protein oxidation or denaturation, nuclear
acid oxidation, andmany othermacromolecular changes that
can lead to serious cellular damage [6]. Such ROS-related
damage has been identified to occur in numerous diseases,
including metabolic syndrome, diabetes, multiple types of
cancer, Alzheimer’s disease, and cardiovascular diseases.
Further, obesity, hyperglycemia, and hyperlipidemia have
also been shown to promote oxidative stress through elevated
ROS production [7], which is likely due to the higher occur-
rence of mitochondrial dysfunction and superoxide produc-
tion that has been associatedwith fat accumulation [8].Under
normal conditions, enzymatic defence mechanisms [9], such
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as scavenging by superoxide dismutase [10] and glutathione
peroxidase, are active in most types of cells to degrade ROS
and prevent cellular damage. However, the antioxidant defe-
nce system functioning in insulin producing beta cells, which
have been linked to both diabetes and obesity, is known to be
very weak [1, 11, 12], making these beta cells highly sensitive to
oxidative stress, which can lead to cell death and disease [5].
Notably, the prevention of ROS-related beta cell destruction
using antioxidant compounds has been identified to be an
effective strategy to delay the onset of diabetes [10, 13, 14].
In fact, several dietary plants that have pharmacological
properties shown to prevent apoptosis induced by oxidative
stress are under investigation as treatment options for dia-
betes [9, 15]. Some of these plants appear to utilize antioxidant
mechanisms related to their rich flavonoid (polyphenols fam-
ily) content. The unique chemical structures and redox pro-
perties of these polyphenols [16] allow them to scavenge free
radicals as well as chelate transitionmetals and inhibit proox-
idant enzymes, such as inducible nitric oxide synthase (iNOS)
in macrophages [17]. For example, tea catechins, especially
epigallocatechin gallate (EGCG), appear to have antiobesity
and antidiabetic properties [11, 18], and the beneficial effects
of red wine polyphenols (RWPs) in diabetics have been
widely documented [19]. RWPs are qualitatively and quanti-
tatively rich in polyphenols, particularly anthocyanins, flav-
onol, and stilbene. In general, polyphenols are characterized
by antioxidant activity and in vitro studies have shown that
they act as radical peroxyl scavengers [20]. However, most of
these in vitro studies were performed using a single model of
stress, such as hypoxanthine/xanthine oxidase (HX/XO) [21]
or H
2
O
2
[22, 23], whereby HX/XO was a direct supplier in
O2
−, while H
2
O
2
activated NADPH oxidase or NOS which
produce O2
−. In diabetes, in addition to O2
−∙, generated by
chronic hyperglycemia [4], other types of ROS are produced
during insulin resistance and hyperinsulinism development
[24]. Therefore, a single model of oxidative stress does not
reflect the full complexity of this disease. In more relevant
studies, oxidative stress was induced bymultiple mechanisms
using cytokines [25], alloxan [26], or streptozotocin [9, 27].
Notably, STZ is an NO donor and induces the formation
of several kinds of ROS (e.g., O2
−∙, H
2
O
2
, OH∙, and per-
oxynitrite; Szkudelski, 2001) as well as DNA alkylation and
tricarboxylic citric acid (TCA) cycle inhibition, all of which
lead to cell damage and death. Thus, STZ can be used to
inducemultiple levels of oxidative stress in order tomore app-
ropriately mimic that which occurs during diabetes in vivo.
Obviously the oxidative stress observed during diabetes is
complex, and the screening of antioxidant compounds can-
not be reduced to the use of a single chemical stress. It is
therefore important to validate the antioxidant properties of
each antioxidant treatment compound, such as the RWPs,
using both simple (single) and complex (multiple) oxidative
mechanisms.The aim of this study was to create three in vitro
models of oxidative stress (one with single radicals produced
by HX/XO and two with more complex oxidative reactions
using H
2
O
2
and STZ) in order to assess the antioxidant
efficiencies of a RWP extract and a purified extract of EGCG.
2. Materials and Methods
2.1. Cell Line. Rat insulinoma clonem5F (RINm5F) [28] cells
were purchased from the American Type Culture Collection
(ATCC, Manassas, USA). Cells were cultivated in Roswell
Park Memorial Institute (RPMI-1640) medium supplemen-
ted with 10% fetal bovine serum (FBS; Sigma, St. Louis, USA)
and 1% antibiotic-antimycotic (ABAM; Gibco, Invitrogen,
Grand Island, USA). Cells were grown in a humidified 5%
CO
2
atmosphere at 37∘C and trypsinized at 80% confluence
using 0.05% trypsin EDTA (Sigma). Medium was refreshed
every 48 hours.
2.2. Antioxidant Molecules. The RWP extract used in this
study was generously given by Dr. M. Moutounet (National
Institute of Agronomic Research, Montpellier, France). Red
wine phenolic extract dry powder was obtained from French
redwine (Corbie`res AOC) and analyzed byDr. P.-L. Teissedre
(De´partement d’Oenologie, Bordeaux, France). The extract
was prepared as previously described [29]: briefly, phenolic
compounds were adsorbed on a preparative column and,
then, alcohol desorbed; the alcoholic eluent was gently evap-
orated; the concentrated residue was lyophilized and finely
sprayed to obtain the phenolic extract dry powder. One liter
of red wine produced 2.9 g of phenolic extract, which con-
tained 471mg/g of total phenolic compounds expressed as
gallic acid. Phenolic levels in phenolic extract were mea-
sured by HPLC. The extract contained 8.6mg/g catechin,
8.7mg/g epicatechin, dimers (B1: 6.9mg/g, B2: 8.0mg/g,
B3: 20.7mg/g, and B4: 0.7mg/g), anthocyanins (malvidin-
3-glucoside: 11.7mg/g, peonidin-3-glucoside: 0.66mg/g, and
cyanidin-3-glucoside: 0.06mg/g), and phenolic acids (gal-
lic acid: 5.0mg/g, caffeic acid: 2.5mg/g, and caftaric acid:
12.5mg/g).
A stock solution of this RWP extract was prepared by
diluting 10mg/mL in a 1 : 1 mixture of distilled water and
100% ethanol. The EGCG extract was a pure form of green
tea Teavigo (DSM Nutritional Product, Gland, Switzerland).
To confirm its purity, Teavigo was analysed using chromato-
graphic separation on a octadecylsilyl silica gel LC column
(l: 0.125mm; d: 4; 0mm; Thermo Scientific, France) with
spherical particles. Mobile phase consisted of water : formic
acid (0.1%, phase A) and methanol : formic acid (0.1%, phase
B). A split systemwas used allowing the HPLC eluate to enter
the MS detector at a flow rate of 0.2mL/min. The injection
volume was 20𝜇L. UV spectral data were acquired at 275 nm
(the chromatogram was presented in Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2015/859048).
The extract was prepared at a 10mg/mL stock solution con-
centration which was then diluted in 1× phosphate-buffered
saline (PBS), pH 7.4 (Gibco, Invitrogen) as previously descri-
bed [18]. Cells were cultured for 48 hours before all treat-
ments. The antioxidant compounds (200 to 1000 pg/mM for
the EGCG and 100 to 1000 𝜇g/mL for the RWPs) were added
to cells seeded in 96-well treated microplates (BD Falcon,
Franklin Lakes, USA) at 30,000 cells/well and incubated for
1 hour. The toxicity of the EGCG and RWP extracts was then
assessed as described below.
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2.3. Oxidative Stress Induction and Protective Effects of EGCG
and RWPs. Oxidative stress was induced in the RINm5F cells
with (1) H
2
O
2
using a 33% daily prepared solution [30] that
was diluted with culture medium to multiple concentrations
(1, 10, 25, and 40 𝜇mol/L); (2) amixture of variousHX (mmol/
L) to XO (mU/mL) ratios (0.05/2, 0.2/8, 0.25/10, and 0.3/12)
isolated frombuttermilk [22]; and (3) a 40 𝜇mol/L solution of
STZ prepared in 0.1mol/L citrate buffer solution, pH 4.2 (27,
25, and 40 𝜇mol/L, prepared in pH 4.2 citrate buffer solution
(0.1mol/L)) [27]. All products were purchased from Sigma.
To evaluate the toxicity of the EGCG and RWP antioxi-
dants alone, various concentrations (EGCG at 200, 500, and
1000 𝜇g/mL; RWPs at 10, 50, 100, 150, and 200 𝜇g/mL) were
added to stressed and unstressed cells and incubated for 1
hour.
2.4. MTS Assay. Cell viability was assessed by measuring the
mitochondrial activity with the CellTiter 96 AQueous One
Solution Cell Proliferation Assay from Promega Corporation
(Madison, USA). After treatment, 100 𝜇L of culture medium
containing 20𝜇L of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carbo
xymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
was added. Cells were incubated for 2 hours at 37∘C, in
5% CO
2,
and the absorbance was measured at 490 nm with
a Metertech 960 microplate reader (Metertech Inc., Taipei,
Taiwan). The quantity of the formazan product was directly
proportional to the mitochondrial activity related to number
of living cells. Results are expressed as the percentage of cell
viability compared to the appropriate negative controls.
2.5. Flow Cytometry
2.5.1. Caspase 8. Oxidative stress often affects the cells very
quickly, making it difficult to identify the primary apoptotic
effects of the ROS. Therefore, the expression and/or activity
of initiator caspases, such as caspase 8 [31], are often used
to study apoptosis in this context as they reflect the initial
effects of oxidative stress. Here, the activity of caspase 8 was
determined by flow cytometry using fluorescent inhibitor of
activated caspase 8 (caspase 8 FAM; Millipore, Guava Tech-
nologies, Hayward, CA). Briefly, cells were seeded in 96-
well treated microplates (BD Falcon, Franklin Lakes, USA) at
30,000 cells/well. After treatment, fresh medium supplemen-
ted with 10 𝜇L of caspase inhibitor was added. After mixing,
plates were incubated for 1 hour at 37∘C and centrifuged for 5
minutes at 300×g. Cells were then resuspended and 200𝜇L of
7-aminoactinomycin D (7󸀠AAD) was added and incubated
for 10 minutes at room temperature in the dark before ana-
lysis. A Guava Easycyte microcapillary flow cytometer (Mil-
lipore) was used with laser excitation at 488 nm in order to
detect caspase 8 FAM emission at 517 nm with carboxyfluo-
rescein [6] according to the manufacturer’s instructions. For
each assay, 200 cellular events were collected. Results were
analysed with CytoSoft software (Guava Technologies Inc.,
Hayward, CA, USA) and are expressed as the percentage of
stained cells.
2.5.2. ROS Production. Cells were seeded in 24-well treated
microplates (BD Falcon, Franklin Lakes, USA) at 500,000
cells/well. After treatment, 500𝜇L of fresh medium supple-
mented with 2󸀠,7󸀠-dichlorofluorescein diacetate (DCFH-DA;
Sigma) at final concentration of 5𝜇M[32] was added. DCFH-
DA is deacetylated by a membrane esterase, forming DCFH,
which is then transformed by intracellular H
2
O
2
to a fluores-
cent molecule [28]. Cells were incubated for 1 hour and then
trypsinized. After centrifugation during 10 minutes (500×g),
pellets were dissolved with 500 𝜇L PBS and 200𝜇L of the cell
solution was transferred to 96-well treated microplates. The
suspended cells were then treated with 10 𝜇L of propidium
iodide [11] for 15minutes and assayed for fluorescence by flow
cytometry at 530 nm. Assays were analyzed with CytoSoft
software and the results are expressed as a percentage of ROS
production (DCF-labelled cells) compared to the appropriate
negative controls.
2.6. Antioxidant Enzyme Expression: Catalase (CAT) and
Manganese Superoxide Dismutase (MnSOD). Protein extra-
cts were prepared from the treated cells using lysis buffer
containing 20mMTris ultrapure pH 8 (Euromedex,Mundol-
sheim, France), 137mM NaCl (Sigma), 1% Igepal CA-630
(Sigma), 31mM phenyl methyl sulfonide fluoride (Eurobio,
Les Ulis, France), and 10% glycerol (Sigma) with protease
inhibitor Complete Mini 1X (Roche, Indianapolis, USA).The
protein content of each was measured using the methods of
Bradford [33].
A 50 𝜇g aliquot of the total protein was then separated on
4–12% Bis-Tris Criterion XT Precast Gels (Bio-Rad), trans-
ferred to 0.45 𝜇m nitrocellulose membranes (Bio-Rad), and
detected with the following primary antibodies: anti-catalase
produced in mouse (Sigma) or anti-MnSOD produced in
rabbit (Sigma), each diluted to 1/1000e, as well as a 1/5000e
dilution of anti-𝛽-actin monoclonal antibody produced in
mouse. All antibodies were diluted in blocking buffer
from the WesternBreeze Chemiluminescent Kit (Invitrogen,
Grand Island, USA) overnight at 4∘C. Secondary antibody
solution (anti-mouse (1/2000) or anti-rabbit (1/4000) coupled
to alkaline phosphatase) was incubated with the membranes
for 30 minutes with continuous rotation as described in the
kit. Membranes were then exposed with a Bio-Rad Chemi-
Doc XRS System for 600 seconds, and the captured images
were analysed using Quantity One software. Expression of
CAT and MnSOD proteins was normalized to the quantity
of 𝛽-actin and expressed as a percentage compared to the
appropriate negative controls.
2.7. Statistical Analysis. Samples were assayed at least three
times for each test and the results are given as the mean ±
standard error (SEM). Data were analysed with one-way
analysis of variance [34] when designated using the Statistica
program (Statsoft©, Cre´teil, France). Treatment differences
were subjected to Fischer’s test with a 95% significance (𝑃 <
0.05) threshold.
3. Results
3.1. Cellular Effects of Various Oxidative Stressors. We first
screened the cell viability following treatment with multiple
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Figure 1: Effects of H
2
O
2
(a), HX/XO (b), and STZ (c) on RINm5F cell viability. Values are given as the mean ± SEM for three different
experiments. 𝑛 = 6; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 compared to the control cells.
concentrations of each oxidative molecule to determine the
concentration of each that induced RINm5F cell death in at
least 50% of the culture (Figure 1). H
2
O
2
appears to induce a
significant decrease in cell viability at concentrations above
25 𝜇mol/mL (𝑃 < 0.01), with the lowest number of viable
cells reaching 21.4 ± 0.5% at the 40 𝜇mol/mL concentration
(Figure 1(a)). Further, a ratio of 0.25mmol/L of HX and
10mU/mL of XO was sufficient to induce a significant loss
of cell viability, resulting in only 45.9 ± 9.2% of the cells
being viable at this ratio (𝑃 < 0.01) (Figure 1(b)). Finally,
even though the 10mmol/L concentration of STZ induced
a significant decrease in cell viability, leaving only 76.5 ±
0.7% of the cells (𝑃 < 0.01), a more marked reduction
of cell viability similar to that of the other oxidants was
observed at 25mmol/L, which resulted in only 32 ± 1.6%
of the cells remaining alive in the culture (𝑃 < 0.01)
(Figure 1(c)). Concentrations that induced a loss greater than
50% (25 𝜇mol/L of H
2
O
2
, a ratio of 0.25mmol/L of HX and
10mU/mL of XO, and 25mmol/L of STZ) were the sole
concentrations used in the subsequent analyses to study the
antioxidant properties of the EGCG and RWP extracts.
3.2. Antioxidant Toxicity Assessment. The potential toxicity
of each antioxidant extract on the unstressed RINm5F cells
was evaluated by measuring the cell viability in the presence
of different concentrations of EGCG and RWPs (Figure 2).
RWPs appear to have no effect on cell viability until reaching
a concentration of 500 𝜇g/mL, at which point the number of
viable cells drops to 92.4 ± 14.7% (not significant). A dose-
dependent decreasing trend in cell viability was also observed
around this concentration; however, this decrease was not
significant until the RWP concentration reached 1000 𝜇g/mL
(𝑃 < 0.05) (Figure 2(a)). In contrast, EGCG was observed to
induce a significant increase in cell viability at the 500𝜇g/mL
(152 ± 26%, 𝑃 < 0.01) and 1000𝜇g/mL (233.5 ± 13.0%,
𝑃 < 0.01) concentrations (Figure 2(b)).
3.3. Effects of EGCG and RWPs during H2O2-Induced Oxida-
tive Stress. RWPs were shown to reduce the loss of RINm5F
cell viability induced by H
2
O
2
oxidative stress (Figure 3(a))
in a dose-dependent manner starting at a concentration of
50 𝜇g/mL (32.4 ± 1.8%, 𝑃 < 0.01) and reaching a maximum
level at 200𝜇g/mL (73.9 ± 3.5%, 𝑃 < 0.01), the highest
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Figure 2: Effects of RWPs (a) and EGCG (b) on RINm5F cell viability. Values are given as the mean ± SEM for three different experiments.
𝑛 = 6; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 compared to the control cells.
concentration used in this study. Further, 500𝜇g/mL of
EGCG was sufficient to significantly improve cell viability
after oxidative stress (82.3 ± 6.2%, 𝑃 < 0.01) (Figure 3(b)).
This effect again appeared to be dose-dependent, with the cell
viability being completely restored and enhanced at an EGCG
concentration of 1000 𝜇g/mL (110 ± 8.9%, 𝑃 < 0.01).
The antioxidant properties of RWPs and EGCG were
also confirmed by measuring apoptosis through the evalu-
ation caspase 8 expression using 150 𝜇g/mL of RWPS and
500𝜇g/mL of EGCG. Both antioxidants appear to reduce the
significant increase in caspase 8 activation observed during
H
2
O
2
-induced oxidative stress back to levels similar to the
unstressed control cells (𝑃 < 0.01). Surprisingly, the sig-
nificant increase in ROS production observed during H
2
O
2
oxidative stress was not reduced by the RWP extract; it actu-
ally appeared to induce an increase in ROS production, going
from 11.1±2.1% to 19.2±1.9% (𝑃 < 0.01). On the other hand,
EGCG extract significantly reduced ROS production during
oxidative stress. In terms of antioxidant enzyme expression
during H
2
O
2
-induced oxidative stress, MnSOD (Figure 3(e))
and CAT protein expression (Figure 3(f)) was comparable to
that of the unstressed control cells. Further, MnSOD protein
expression was significantly reduced by RWPs during oxida-
tive stress (𝑃 < 0.05), while CAT protein expression was
reduced using EGCG (𝑃 < 0.01).
3.4. Effects of EGCG and RWPs on HX/XO-Induced Oxida-
tive Stress. The significant decrease RINm5F cell viability
observed during HX/XO-induced oxidative stress was signif-
icantly increasedwhen 200𝜇g/mLof RWPwas added, but the
percentage of viable cells did not exceed 40.2±1.9%(𝑃 < 0.01)
(Figure 4(a)).The efficiency of EGCG to improve the viability
of stress cells was similar to that observed for RWPs at the
200𝜇g/mL concentration (43.1±3.8%), although this was not
significant (Figure 4(b)). However, at higher concentrations
EGCG was able to significantly increase cell viability from
16.5 ± 2.1% in the stressed control cells to 88.5 ± 7.4% at
500𝜇g/mL (𝑃 < 0.01) and over 100% at the 1000 𝜇g/mL
concentration.
Further, the 150 𝜇g/mL and 500𝜇g/mL concentrations
of RWPs and EGCG, respectively, were then used to study
their antioxidant properties during HX/XO-induced oxida-
tive stress. It appears that these concentrations of RWPs
and EGCG significantly reduce caspase 8 cleavage during
HX/XO-induced oxidative stress (𝑃 < 0.05 and 𝑃 < 0.01,
resp.; Figure 4(c)), bringing the caspase 8 activity back down
to levels similar to the unstressed control cells. Moreover,
both antioxidants significantly reduced the ROS production
as well (Figure 4(d)). Notably, only EGCG was observed to
increase the protein expression of MnSOD (Figure 4(e)) and
CAT (Figure 4(f)) during HX/XO-induced oxidative stress.
3.5. Effects of EGCG and RWPs on STZ-Induced Oxidative
Stress. The significant decrease in cell viability during STZ-
induced oxidative stress was slightly opposed by 200𝜇g/mL
of RWPs, which significantly increased the number of viable
cells to amere 50.6±0.5% (𝑃 < 0.01). Similarly, a 1000 𝜇g/mL
concentration of EGCG was needed to significantly increase
the cell viability during STZ-induced oxidative stress (60 ±
14%, 𝑃 < 0.05) (Figure 5(b)). For further investigation
of the antioxidant properties of the RWPs and EGCG extracts
during this type of oxidative stress, we focused on the 200𝜇g/
mL and 1000 𝜇g/mL concentrations of RWPs and EGCG,
respectively.
Notably, caspase 8 activationwas not observed to increase
during STZ-induced oxidative stress; the addition of either of
the antioxidants did not significantly change these levels com-
pared to the unstressed or stressed control cells (Figure 5(c)).
However, the production of ROS was significantly increased
during STZ-induced stress and only EGCG treatment caused
a significant reduction of this induced ROS production (𝑃 <
0.05; Figure 5(d)). The unaltered MnSOD (Figure 5(e)) and
CAT (Figure 5(f)) protein expression during STZ-induced
oxidative stress was also only affected by the addition of
EGCG.
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Figure 3: Effects of the antioxidants RWPs and EGCG on cell viability (a, b), caspase 8 activity/apoptosis (c), ROS production (d), MnSOD
expression (e), and CAT expression (f) during H
2
O
2
-induced oxidative stress. Values are given as the mean ± SEM for three different
experiments. 𝑛 = 6; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 compared to the unstressed control cells (CTL−); #𝑃 < 0.05, ##𝑃 < 0.01 compared to
the stressed control cells (CTL+); §𝑃 < 0.05, §§𝑃 < 0.01, and §§§𝑃 < 0.001 compared to the stressed cells treated with RWPs.
4. Discussion
In the present study, we sought to accurately determine the
antioxidant properties of two specific natural compounds,
RWPs and EGCG. In doing so, we have demonstrated that
antioxidant properties depend not only on the nature of the
compound itself, but also on the type of oxidative stress
induced. These data show, for the first time, that using one
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Figure 4: Effects of the antioxidants RWPs and EGCG on cell viability (a, b), caspase 8 activity/apoptosis (c), ROS production (d), MnSOD
expression (e), and CAT expression (f) during HX/XO-induced oxidative stress. Values are given as the mean ± SEM for three different
experiments. 𝑛 = 6; ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001 compared to the unstressed control cells (CTL−); #𝑃 < 0.05, ##𝑃 < 0.01
compared to the stressed control cells (CTL+); §§𝑃 < 0.01 compared to the stressed cells treated with RWPs.
model of oxidative stress is not sufficient to make meaningful
conclusions concerning the action of an antioxidant, partic-
ularly in regard to disease-related oxidative stress.
Complexmechanisms related to glucose autoxidation and
hyperinsulinism, which increase ROS production, have been
identified in diabetes [5]. Further, the increased level of ROS
has been associated with beta cell apoptosis, which, in time,
induces insulin dependence [34, 35]. In order to decrease beta
cell oxidative stress, nutraceutical approaches have been
developed focusing on the screening of plant extract [36–38].
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Figure 5: Effects of the antioxidants RWPs and EGCG on cell viability (a, b), caspase 8 activity/apoptosis (c), ROS production (d), MnSOD
expression (e), and CAT expression (f) during STZ-induced oxidative stress. Values are given as the mean ± SEM for three different
experiments. 𝑛 = 6; ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001 compared to the unstressed control cells (CTL−); #𝑃 < 0.05, ##𝑃 < 0.01
compared to the stressed control cells (CTL+); §𝑃 < 0.05, §§§𝑃 < 0.001 compared to the stressed cells treated with RWPs.
For the initial screening, the efficiency of the bioactive comp-
ounds in the plant is currently validated in vitro using a single
type of oxidative stress [27, 39–41]. Here, in order to provide
a comprehensive overview of ROS generated in diabetes, we
have utilized three models of oxidative stress to screen our
bioactive compounds.
Not surprisingly, the level of cell death induced by each
type of oxidative stress studiedwas similar. However, the level
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of ROS produced in the cells was found to be higher in the
HX/XOmodel compared to the others. In fact, our data show
that there is no correlation between ROS production and the
level of cell death, indicating that cell viability alone is not an
accurate marker of the oxidative stress response in a cell or
tissue.This is in contrast to several previous studies that have
linked oxidative stress to cell viability [3, 26, 28]. Notably, the
conclusions in these studies were all based on single models
of oxidative stress. We chose to measure ROS production in
parallel with other markers of the cellular stress response,
such as changes in SOD and CAT expression as well as the
caspase 8 activity in the cells, in order to evaluate the full effect
of the oxidant. According to these results, the cellular defence
mechanisms, characterised by SOD and CAT expression,
were more activated by the HX/XO-induced stress, which is
correlated to the higher level of ROS. Thus, we suggest that
antioxidant enzymes likely play a crucial role in cell protec-
tion following the introduction of oxidative stress, particu-
larly because the cell viability was comparable to the other
conditions as previously described [21, 40].This phenomenon
in the HX/XO experiments could also be explained by the
type of radical generated. In fact, the stress induced by H
2
O
2
and STZ was more complex (ROS generation via NADPH
oxidase activation and/or NO synthase) compared to that
generated byHX/XO (direct ROSprovider), whichmay result
in the latter inducing the cell’s response to stress earlier or
more efficiently. Additional work is necessary to further elu-
cidate the differing effects caused by the various free radicals.
Using the three stress models outlined here in conjunc-
tion with parallel investigations of ROS generation and cel-
lular defence mechanisms to screen bioactive compounds
also providedmore detailed information on the cellular stress
response. For example, in these experiments, EGCGappeared
to be a better antioxidant for the three types of different
stresses induced, with a decrease in ROS production and an
activation of MnSOD and CAT expression, whereas RWPs
were shown to be efficient only on the strongest stress
(HX/XO) and even then only had a limited influence on anti-
oxidant enzyme expression. Thus, the use of multiple types
of free radical stress indicates that EGCG is likely the most
efficient scavenger [26] and pharmacological treatment [37]
investigated in this study. This is corroborated by a previous
study that demonstrated the neuroprotective effects of EGCG
involving inhibition of the Fenton reaction and upregulation
of several antioxidant enzymes, such as superoxide dismutase
and catalase, resulting in the attenuation of oxidative stress
[42]. In contrast, the antioxidant properties of RWPs seem
to be solely related to scavenging during severe changes in
oxidative stress. Moreover, our study suggests that RWPsmay
be both antioxidant and prooxidant because we observed an
increase of ROS production when RPWs were added during
H
2
O
2
oxidative stress. It is well known [43] that polyphenols
extract could autoxidize and produce more hydrogen perox-
ide. In our study, we have demonstrated in this condition that
RWPs have no impact on SODor CAT protein expression but
other protectivemechanisms could be activated like the stim-
ulation ofCATand SODactivity or a direct action glutathione
or thioredoxin. Notably, while we sought to use the same
concentration of compound (pure or extract) for both RWPs
and EGCG, the composition of these compounds made this
impractical. Using HPLC [29], it appears that the raw RWP
extract also contains several flavonoids (epicatechin, cate-
chin, and gallic acid) but is found at concentrations that are
100 times less than that of the pure EGCG used in this study.
This composition could explain the relatively low efficiency
of RWPs shown here. In contrast, the pure EGCG extract
was able to activate antioxidant pathways through several
mechanisms, which could be due to the high concentra-
tion of the flavonoids present.
Regardless of the composition of the compounds, if only
one oxidative stress model had been used or only one ROS
or cell death assay had been performed, then it is unlikely
that the complex nature of these antioxidants would have
been uncovered. Therefore, we believe that the sole use of
one model or one assay to validate the efficiency of bioactive
compounds in the current literature [30, 32] greatly limits
the scope and conclusions of these studies. Further, a more
precise determination of cell death, ideally using additional
apoptosis signalling pathways, like additional caspase activa-
tion, antiapoptotic Bcl-xL, and proapoptotic Bax expression
[27, 37], as well as further analysis of oxidation-related
enzymes could also be utilized to expand our current analysis.
Additional work is necessary to determine the full function-
ality of our multitype oxidative stress model in testing the
antioxidant properties of other compounds.
5. Conclusion
Here, we have demonstrated that the level of ROS gener-
ated by different oxidative stresses was variable and a drug
screening using a single kind of stress can introduce bias in
the estimation of the antioxidant properties of a compound.
Therefore, a combination of several stresses and several cellu-
lar and molecular approaches would provide a more accurate
experimental text to determine if the compound is an
efficient antioxidant.This in vitromodel also more accurately
mimics the in vivo biological situation, which will help avoid
unnecessary spending of money and time when transitioning
a bioactive antioxidant treatment from the context of cell
culture to clinical validation. Taken together, this study
provides a much neededmethod for the comprehensive asse-
ssment of antioxidants for the treatment of oxidative stress-
related diseases.
Abbreviations
7󸀠AAD: 7-Aminoactinomycin D
ABAM: Antibiotic-antimycotic
CAT: Catalase
DCF: Dichlorofluorescein
DCFH-DA: 2󸀠,7󸀠-Dichlorofluorescein-diacetate
DNA: Deoxyribonucleic acid
EDTA: Ethylenediaminetetraacetic acid
EGCG: Epigallocatechin gallate
FAM: Carboxyfluorescein
FBS: Fetal bovine serum
HX/XO: Hypoxanthine/xanthine oxidase
10 Evidence-Based Complementary and Alternative Medicine
iNOS: Inducible NO synthase
MnSOD: Manganese superoxide dismutase
NO: Nitric oxide
PBS: Phosphate-buffered saline
RINm5F: Rat pancreatic cell line
ROS: Reactive oxygen species
RWPs: Red wine polyphenols
SEM: Standard error of the mean
SOD: Superoxide dismutase
STZ: Streptozotocin
TCA: Tricarboxylic citric acid.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgments
The authors would like to express their gratitude to “Vaincre
le Diabe`te” and ASDIA (Assistance Service DIAbete) for par-
tially funding this project.
References
[1] K. Grankvist, S. L. Marklund, and I. B. Taljedal, “CuZn-
superoxide dismutase, Mn-superoxide dismutase, catalase and
glutathione peroxidase in pancreatic islets and other tissues in
the mouse,” Biochemical Journal, vol. 199, no. 2, pp. 393–398,
1981.
[2] H. Sies, “Role of reactive oxygen species in biological processes,”
Klinische Wochenschrift, vol. 69, no. 21–23, pp. 965–968, 1991.
[3] S. R. Sampson, E. Bucris, M. Horovitz-Fried et al., “Insulin
increases H
2
O
2
-induced pancreatic beta cell death,” Apoptosis,
vol. 15, no. 10, pp. 1165–1176, 2010.
[4] A. Y. Andreyev, Y. E. Kushnareva, andA.A. Starkov, “Mitochon-
drial metabolism of reactive oxygen species,” Biochemistry, vol.
70, no. 2, pp. 200–214, 2005.
[5] S. Lenzen, “The mechanisms of alloxan- and streptozotocin-
induced diabetes,”Diabetologia, vol. 51, no. 2, pp. 216–226, 2008.
[6] A. Favier, “Oxidative stress in human diseases,” Annales Phar-
maceutiques Francaises, vol. 64, no. 6, pp. 390–396, 2006.
[7] K. Fisher-Wellman and R. J. Bloomer, “Macronutrient specific
postprandial oxidative stress: relevance to the development of
insulin resistance,” Current Diabetes Reviews, vol. 5, no. 4, pp.
228–238, 2009.
[8] M.D. Brand, A. L.Orr, I. V. Perevoshchikova, andC. L.Quinlan,
“The role of mitochondrial function and cellular bioenergetics
in ageing and disease,” British Journal of Dermatology, vol. 169,
no. 2, pp. 1–8, 2013.
[9] M. Latha, L. Pari, S. Sitasawad, and R. Bhonde, “Scoparia dulcis,
a traditional antidiabetic plant, protects against streptozotocin
induced oxidative stress and apoptosis in vitro and in vivo,”
Journal of Biochemical and Molecular Toxicology, vol. 18, no. 5,
pp. 261–272, 2004.
[10] C. Go¨kkus¸u, S¸. Palanduz, E. Ademog˘lu, and S. Tamer, “Oxidant
and antioxidant systems in niddmpatients: influence of vitamin
E supplementation,” Endocrine Research, vol. 27, no. 3, pp. 377–
386, 2001.
[11] H. P. Ammon, R. Ha¨gele, N. Youssif, R. Eujen, and N. El-
Amri, “A possible role of intracellular and membrane thiols
of rat pancreatic islets in calcium uptake and insulin release,”
Endocrinology, vol. 112, no. 2, pp. 720–726, 1983.
[12] S. Lenzen, J. Drinkgern, and M. Tiedge, “Low antioxidant
enzyme gene expression in pancreatic islets compared with
various othermouse tissues,” Free Radical Biology andMedicine,
vol. 20, no. 3, pp. 463–466, 1996.
[13] R. Ha¨gerkvist, S. Sandler, D. Mokhtari, and N. Welsh, “Amelio-
ration of diabetes by imatinib mesylate (Gleevec): role of beta-
cell NF-kappaB activation and anti-apoptotic preconditioning,”
The FASEB Journal, vol. 21, no. 2, pp. 618–628, 2007.
[14] S. M. Virtanen and A. Aro, “Dietary factors in the aetiology of
diabetes,” Annals of Medicine, vol. 26, no. 6, pp. 469–478, 1994.
[15] R. A. Kinloch, J. M. Treherne, L. M. Furness, and I. Hajimo-
hamadreza, “The pharmacology of apoptosis,” Trends in Phar-
macological Sciences, vol. 20, no. 1, pp. 35–42, 1999.
[16] C. Rice-Evans, “Plant polyphenols: free radical scavengers or
chain-breaking antioxidants?” Biochemical Society symposium,
vol. 61, pp. 103–116, 1995.
[17] A. Sarkar and A. Bhaduri, “Black tea is a powerful chemo-
preventor of reactive oxygen and nitrogen species: comparison
with its individual catechin constituents and green tea,” Bio-
chemical and Biophysical Research Communications, vol. 284,
no. 1, pp. 173–178, 2001.
[18] Y.-H. Kao, H.-H. Chang, M.-J. Lee, and C.-L. Chen, “Tea,
obesity, and diabetes,” Molecular Nutrition and Food Research,
vol. 50, no. 2, pp. 188–210, 2006.
[19] R. Rodrigo, A. Miranda, and L. Vergara, “Modulation of endo-
genous antioxidant system by wine polyphenols in human
disease,” Clinica Chimica Acta, vol. 412, no. 5-6, pp. 410–424,
2011.
[20] C. Sandoval-Acun˜a, J. Ferreira, and H. Speisky, “Polyphenols
and mitochondria: an update on their increasingly emerging
ROS-scavenging independent actions,”Archives of Biochemistry
and Biophysics, vol. 559, pp. 75–90, 2014.
[21] S. Lortz and M. Tiedge, “Sequential inactivation of reactive
oxygen species by combined overexpression of SOD isoforms
and catalase in insulin-producing cells,” Free Radical Biology
and Medicine, vol. 34, no. 6, pp. 683–688, 2003.
[22] C. Moriscot, M. J. Richard, M. C. Favrot, and P. Y. Benhamou,
“Protection of insulin-secreting INS-1 cells against oxidative
stress through adenoviral-mediated glutathione peroxidase
overexpression,” Diabetes and Metabolism, vol. 29, no. 2 I, pp.
145–151, 2003.
[23] R. Zhang, Q. Zhang, J. Niu et al., “Screening of microRNAs
associated with Alzheimer’s disease using oxidative stress cell
model and different strains of senescence accelerated mice,”
Journal of the Neurological Sciences, vol. 338, no. 1-2, pp. 57–64,
2014.
[24] A. Ceriello and E. Motz, “Is oxidative stress the pathogenic
mechanism underlying insulin resistance, diabetes, and car-
diovascular disease? The common soil hypothesis revisited,”
Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no.
5, pp. 816–823, 2004.
[25] K.-B. Kwon, J.-H. Kim, Y.-R. Lee et al., “Amomum xanthoides
extract prevents cytokine-induced cell death of RINm5F cells
through the inhibition of nitric oxide formation,” Life Sciences,
vol. 73, no. 2, pp. 181–191, 2003.
[26] K.M. Ramkumar, A. S. Lee, K. Krishnamurthi et al., “Gymnema
montanumH. Protects against alloxan-induced oxidative stress
Evidence-Based Complementary and Alternative Medicine 11
and apoptosis in pancreatic 𝛽-cells,” Cellular Physiology and
Biochemistry, vol. 24, no. 5-6, pp. 429–440, 2009.
[27] S. A. Kalekar, R. P. Munshi, and U. M. Thatte, “Do plants
mediate their anti-diabetic effects through anti-oxidant and
anti-apoptotic actions? An in vitro assay of 3 Indian medicinal
plants,” BMC Complementary and Alternative Medicine, vol. 13,
article 257, 2013.
[28] K. Dembele, K. H. Nguyen, T. A. Hernandez, and B. L. G.
Nyomba, “Effects of ethanol on pancreatic beta-cell death:
interaction with glucose and fatty acids,” Cell Biology and
Toxicology, vol. 25, no. 2, pp. 141–152, 2009.
[29] C. Auger, B. Caporiccio, N. Landrault et al., “Red wine phenolic
compounds reduce plasma lipids and apolipoprotein B and pre-
vent early aortic atherosclerosis in hypercholesterolemic golden
Syrian hamsters (Mesocricetus auratus),” Journal of Nutrition,
vol. 132, no. 6, pp. 1207–1213, 2002.
[30] A. Mira, A. Tanaka, Y. Tateyama, R. Kondo, and K. Shimizu,
“Comparative biological study of roots, stems, leaves, and seeds
of Angelica shikokianaMakino,” Journal of Ethnopharmacology,
vol. 148, no. 3, pp. 980–987, 2013.
[31] C. H. Kim and Y.-M. Yoo, “Melatonin induces apoptotic cell
death via p53 in LNCaP cells,” Korean Journal of Physiology and
Pharmacology, vol. 14, no. 6, pp. 365–369, 2010.
[32] L. Liu and S.-Y.Wang, “Protective effects of paeoniflorin against
a𝛽25-35-induced oxidative stress in PC12 cells,” Zhongguo
Zhong Yao Za Zhi, vol. 38, no. 9, pp. 1318–1322, 2013.
[33] M. M. Bradford, “A rapid and sensitive method for the quanti-
tation of microgram quantities of protein utilizing the principle
of protein-dye binding,”Analytical Biochemistry, vol. 72, no. 1-2,
pp. 248–254, 1976.
[34] V. Z. Lankin, M. V. Ivanova, G. G. Konovalova, A. K. Tikhaze,
A. I. Kaminnyi, and V. V. Kukharchuk, “Effect of 𝛽-hydroxy-
𝛽-methylglutaryl coenzyme a reductase inhibitors and antioxi-
dant vitamins on free radical lipid oxidation in rat liver,”Bulletin
of Experimental Biology and Medicine, vol. 143, no. 4, pp. 414–
417, 2007.
[35] P. P. Singh, F. Mahadi, A. Roy, and P. Sharma, “Reactive oxygen
species, reactive nitrogen species and antioxidants in etiopatho-
genesis of diabetes mellitus type-2,” Indian Journal of Clinical
Biochemistry, vol. 24, pp. 324–342, 2009.
[36] U. Karunakaran and K.-G. Park, “A systematic review of
oxidative stress and safety of antioxidants in diabetes: focus on
islets and their defense,” Diabetes and Metabolism Journal, vol.
37, no. 2, pp. 106–112, 2013.
[37] S.-H. Lee, S.-M. Kang, S.-C. Ko, M.-C. Kang, and Y.-J. Jeon,
“Octaphlorethol A, a novel phenolic compound isolated from
Ishige foliacea, protects against streptozotocin-induced pancre-
atic beta cell damage by reducing oxidative stress and apoptosis,”
Food and Chemical Toxicology, vol. 59, pp. 643–649, 2013.
[38] M. A´. Mart´ın, S. Ramos, I. Cordero-Herrero, L. Bravo, and L.
Goya, “Cocoa phenolic extract protects pancreatic beta cells
against oxidative stress,” Nutrients, vol. 5, no. 8, pp. 2955–2968,
2013.
[39] L. A. Flores-Lo´pez, M. Dı´az-Flores, R. Garc´ıa-Macedo et al.,
“High glucose induces mitochondrial p53 phosphorylation by
p38 MAPK in pancreatic RINm5F cells,” Molecular Biology
Reports, vol. 40, no. 8, pp. 4947–4958, 2013.
[40] V. Nadithe, D. Mishra, and Y. H. Bae, “Poly(ethylene glycol)
cross-linked hemoglobin with antioxidant enzymes protects
pancreatic islets from hypoxic and free radical stress and
extends islet functionality,” Biotechnology and Bioengineering,
vol. 109, no. 9, pp. 2392–2401, 2012.
[41] F. M. M. Paula, S. M. Ferreira, A. C. Boschero, and K. L. A.
Souza, “Modulation of the peroxiredoxin system by cytokines
in insulin-producingRINm5F cells: down-regulation of PRDX6
increases susceptibility of beta cells to oxidative stress,”Molecu-
lar and Cellular Endocrinology, vol. 374, no. 1-2, pp. 56–64, 2013.
[42] O. Weinreb, T. Amit, S. Mandel, and M. B. H. Youdim, “Neu-
roprotective molecular mechanisms of (−)-epigallocatechin-3-
gallate: a reflective outcome of its antioxidant, iron chelating
and neuritogenic properties,” Genes and Nutrition, vol. 4, no.
4, pp. 283–296, 2009.
[43] J. Zhu, W. J. M. van de Ven, T. Verbiest et al., “Polyphenols can
inhibit furin in vitro as A result of the reactivity of their auto-
oxidation products to proteins,” Current Medicinal Chemistry,
vol. 20, no. 6, pp. 840–850, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
